ID: ALA3736243

Max Phase: Preclinical

Molecular Formula: C9H11Cl2NO

Molecular Weight: 220.10

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(N)COc1c(Cl)cccc1Cl

Standard InChI:  InChI=1S/C9H11Cl2NO/c1-6(12)5-13-9-7(10)3-2-4-8(9)11/h2-4,6H,5,12H2,1H3

Standard InChI Key:  DSZKFIWDWJBDHE-UHFFFAOYSA-N

Associated Targets(non-human)

Right atrium 265 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 220.10Molecular Weight (Monoisotopic): 219.0218AlogP: 2.72#Rotatable Bonds: 3
Polar Surface Area: 35.25Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.52CX LogP: 2.64CX LogD: 0.57
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.85Np Likeness Score: -0.75

References

1. Chau BA, Drummond G, Jackson WR, Jarrott B, Miller AA, Subasinghe KR, Tan CYR, White PJ, Wright CE, Ziogas J.  (2015)  Synthesis of six mexiletine derivatives with isoindolines attached as potential antioxidants and their evaluation as cardioprotective agents,  (4): [10.1039/C4MD00459K]

Source